Neil Schneider, ASA, MAAA
Advertisement
Articles by Neil Schneider, ASA, MAAA
Advertisement
Latest Updated Articles
- Third-Party Validation of Observed Savings From an Oncology Pathways Program
Published: June 18th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL
2
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
3
Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF
4
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
5
